Federal contract award
HHSO100200700032C
ADVANCE DEVELOPMENT OF NEW ANTIVIRAL AGENT FOR INFLUENZA
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541710 |
| PSC | AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $205.0M |
| Current contract value | $205.0M |
| Potential contract value / ceiling | $205.0M |
| Start date | Jan 3, 2007 |
| Current end date | Apr 30, 2014 |
| Potential end date | Apr 30, 2014 |
| Latest award activity | Jan 10, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jan 10, 2025 | P00015 | $-305.9K | THE PURPOSE OF THIS MODIFICATION IS TO DEOBLIGATE EXCESS FUNDS AND CLOSE THIS CONTRACT. IN ACCORDANCE WITH FAR 4.804-5. |
| Dec 31, 2024 | P00014 | $-29.6M | MODIFICATION 12 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.